Profound Medical Corp Cash Flow Conversion Efficiency

Latest as of June 2026: -0.222x

Profound Medical Corp cash flow conversion efficiency. Based on the latest financial reports, Profound Medical Corp (PRN) has a cash flow conversion efficiency ratio of -0.222x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-11.03 Million ≈ $-7.98 Million USD) by net assets (CA$49.73 Million ≈ $35.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Profound Medical Corp (2012–2025)

Cash flow conversion efficiency of Profound Medical Corp from 2012 to 2025. This chart illustrates how Profound Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PRN stock price and chart for real-time trading data and today's change.

Profound Medical Corp Cash Flow Conversion Ratio Explained

Profound Medical Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Profound Medical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Profound Medical Corp ranked by their cash flow conversion efficiency. Also see how much is Profound Medical Corp worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
MM Forgings Limited NSE:MMFL	0.196x
Bpost NV BR:BPOST	0.252x
Jackson Acquisition Company II NYSE:JACS	-0.001x
I-Sheng Electric Wire & Cable Co Ltd TW:6115	-0.007x
Inozyme Pharma Inc NASDAQ:INZY	-0.917x
BIDV Securities JSC VN:BSI	0.055x
Omega Flex Inc NASDAQ:OFLX	0.022x
Cerro de Pasco Resources Inc. V:CDPR	N/A

Annual Cash Flow Conversion Efficiency for Profound Medical Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Profound Medical Corp from 2012 to 2025. Review how financially flexible is Profound Medical Corp to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$66.31 Million ≈ $47.97 Million	CA$-38.88 Million ≈ $-28.12 Million	-0.586x	-51.03%
2024-12-31	CA$60.42 Million ≈ $43.71 Million	CA$-23.45 Million ≈ $-16.97 Million	-0.388x	+46.47%
2023-12-31	CA$31.18 Million ≈ $22.56 Million	CA$-22.61 Million ≈ $-16.36 Million	-0.725x	-46.16%
2022-12-31	CA$52.00 Million ≈ $37.62 Million	CA$-25.80 Million ≈ $-18.66 Million	-0.496x	-78.87%
2021-12-31	CA$80.62 Million ≈ $58.32 Million	CA$-22.36 Million ≈ $-16.17 Million	-0.277x	-31.24%
2020-12-31	CA$97.35 Million ≈ $70.42 Million	CA$-20.57 Million ≈ $-14.88 Million	-0.211x	+84.92%
2019-12-31	CA$14.29 Million ≈ $10.34 Million	CA$-20.03 Million ≈ $-14.49 Million	-1.402x	-104.03%
2018-12-31	CA$19.55 Million ≈ $14.14 Million	CA$-13.43 Million ≈ $-9.72 Million	-0.687x	+47.98%
2017-12-31	CA$11.25 Million ≈ $8.13 Million	CA$-14.85 Million ≈ $-10.75 Million	-1.321x	-0.54%
2016-12-31	CA$11.04 Million ≈ $7.98 Million	CA$-14.50 Million ≈ $-10.49 Million	-1.314x	-167.42%
2015-12-31	CA$10.06 Million ≈ $7.28 Million	CA$-4.94 Million ≈ $-3.58 Million	-0.491x	+76.65%
2014-12-31	CA$1.37 Million ≈ $989.71K	CA$-2.88 Million ≈ $-2.08 Million	-2.104x	-2071.09%
2013-12-31	CA$-29.95 Million ≈ $-21.67 Million	CA$-3.20 Million ≈ $-2.31 Million	0.107x	-43.52%
2012-12-31	CA$-16.17 Million ≈ $-11.70 Million	CA$-3.06 Million ≈ $-2.21 Million	0.189x	--

About Profound Medical Corp

TO:PRN Canada Medical Devices

Market Cap

$258.25 Million

CA$357.00 Million CAD

Market Cap Rank

#15251 Global

#453 in Canada

Share Price

CA$9.77

Change (1 day)

+4.16%

52-Week Range

CA$6.99 - CA$12.11

All Time High

CA$35.63